Literature DB >> 15771358

[Recent data on the physiopathology of preeclampsia and recommendations for treatment].

R Landau1, O Irion.   

Abstract

Maternal hypertension and proteinuria after 20 weeks gestation defines preeclampsia. Severe preeclampsia is defined by severe hypertension or massive proteinuria, with or without symptoms or altered laboratory tests. With an incidence of 4-7%, preeclampsia remains a major cause of maternal and neonatal morbidity and mortality. Admission into a hospital is crucial to monitor both mother and fetus. The only treatment is delivery. Management of blood pressure and prevention of eclampsia with magnesium sulfate is indicated in severe preeclampsia. Despite numerous studies attempting to elucidate the exact etiopathogenesis of this complex multifactorial disease, prediction or prevention of preeclampsia is not available. Preeclampsia has been named the "disease of theories" and remains to date a challenging enigma for the scientific community.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771358

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  4 in total

1.  Socio-demographic and other risk factors of pre eclampsia at a tertiary care hospital, karnataka: case control study.

Authors:  Ramesh K; Sangeetha Gandhi; Vishwas Rao
Journal:  J Clin Diagn Res       Date:  2014-09-20

2.  Placental profiling of UGT1A enzyme expression and activity and interactions with preeclampsia at term.

Authors:  Abby C Collier; Audrey D Thévenon; William Goh; Mark Hiraoka; Claire E Kendal-Wright
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-03       Impact factor: 2.441

3.  A multicentre matched case control study of risk factors for preeclampsia in healthy women in Pakistan.

Authors:  Uzma Shamsi; Juanita Hatcher; Azra Shamsi; Nadeem Zuberi; Zeeshan Qadri; Sarah Saleem
Journal:  BMC Womens Health       Date:  2010-04-30       Impact factor: 2.809

4.  Seasonal variation in the prevalence of preeclampsia.

Authors:  Fatemeh Janani; Farahnaz Changaee
Journal:  J Family Med Prim Care       Date:  2017 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.